Mass spectrometry based proteome profiling of the exhaled breath condensate for lung cancer biomarkers search

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2015;68:394–424.
   Web of Science ®Google Scholar
• Rodrigues M, Ajona D, Seijo LM, et al. Molecular biomarkers in early stage lung cancer. Transl Lung Cancer Res. 2021;10(2):1165–1185.
   PubMed Web of Science ®Google Scholar
• Hoffman RM, Sanchez R. Lung cancer screening. Med Clin North Am. 2017;101(4):769–785.
   PubMed Web of Science ®Google Scholar
• Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012;21(3):308–315.
   PubMed Web of Science ®Google Scholar
• Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease. The randomized danish lung cancer screening trial: status after five annual screening rounds with low-dose CT. Thorax. 2012;67(4):296–301.
   PubMed Web of Science ®Google Scholar
• Kubán P, Foret F. Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review. Anal Chim Acta. 2013;805:1–18.
   PubMed Web of Science ®Google Scholar
• Cainap C, Pop LA, Balacescu O, et al. Early diagnosis and screening in lung cancer. Am J Cancer Res. 2020;10(7):1993–2009.
   PubMed Web of Science ®Google Scholar
• Beck O, Olin A-C, Mirgorodskaya E. Potential of mass spectrometry in developing clinical laboratory biomarkers of nonvolatiles in exhaled breath. Clin Chem. 2016;62(1):84–91.
   PubMed Web of Science ®Google Scholar
• Horvath I, Hunt J, Barnes P, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005;26(3):523–548.
   PubMed Web of Science ®Google Scholar
• Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med. 2001;163(7):1693–1722.
   PubMed Web of Science ®Google Scholar
• Hayes SA, Haefliger S, Harris B, et al. Exhaled breath condensate for lung cancer protein analysis a review of methods and biomarkers. J Breath Res. 2016;10(3):034001.
   PubMed Web of Science ®Google Scholar
• Bredberg A, Gobom J, Almstrand AC, et al. Exhaled endogenous particles contain lung proteins. Clin Chem. 2012;58(2):431–440.
   PubMed Web of Science ®Google Scholar
• Muccilli V, Saletti R, Cunsolo V, et al. Protein profile of exhaled breath condensate determined by high resolution mass spectrometry. J Pharm Biomed Anal. 2015;105:134–149.
   PubMed Web of Science ®Google Scholar
• Lacombe M, Marie-Desvergne C, Combes F, et al. Proteomic characterization of human exhaled breath condensate. J Breath Res. 2018;12(2):021001.
   PubMed Web of Science ®Google Scholar
• Fimagalli M, Ferrari F, Luisetti M, et al. Profiling the proteome of exhaled breath condensate in healthy smokers and COPD patients by LC-MS/MS. Int J Mol Sci. 2012;13(11):13894–13910.
   PubMed Web of Science ®Google Scholar
• Sun C, Zhou T, Xie G, et al. Proteomics of exhaled breath condensate in stable COPD and non-COPD controls using tandem mass tags (TMTs) quantitative mass spectrometry: a pilot study. J Proteomics. 2019;206:103392.
   PubMed Web of Science ®Google Scholar
• Ma L, Muscat J, Sinha R, et al. Proteomics of exhaled breath condensate in lung cancer and controls using data-independent acquisition (DIA): a pilot study. J Breath Res. 2021;15(2):026002.
   Web of Science ®Google Scholar
• Lopez-Sanchez LM, Jurado-Gamez B, Feu-Collado N, et al. Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics. Am J Physiol Lung Cell Mol Physiol. 2017;313(4):L664–L676.
   PubMed Web of Science ®Google Scholar
• Fedorchenko KU, Ryabokon AM, Kononikhin AS, et al. Early diagnosis of lung cancer based on proteome analysis exhaled breath condensate. Moscow Univ Chem Bull. 2016;71(2):134–139.
   Google Scholar
• Núñez-Naveira L, Mariñas-Pardo LA, Montero-Martínez C. Mass spectrometry analysis of the exhaled breath condensate and proposal of Dermcidin and S100A9 as possible markers for lung cancer prognosis. Lung. 2019;197(4):523–531.
   PubMed Web of Science ®Google Scholar
• Chen D, Bryen WA, McLoughlin M. A novel system for the comprehensive collection of nonvolatile molecules from human exhaled breath. J Breath Res. 2020;15(1):016001.
   PubMed Web of Science ®Google Scholar
• van Beurden WJC, Harff GA, Dekhuijzen PNR, et al. An efficient and reproducible method for measuring hydrogen peroxide in exhaled breath condensate. Respir Med. 2002;96(3):197–203.
   PubMed Web of Science ®Google Scholar
• Robroeks CMHHT, Van De Kant KDG, Jobsis Q, et al. Exhaled nitric oxide and biomarkers in exhaled breath condensate indicate the presence, severity and control of childhood asthma. Clin Exp Allergy. 2007;37(9):1303–1311.
   PubMed Web of Science ®Google Scholar
• Soyer OU, Dizdar EA, Keskin O, et al. Comparison of two methods for exhaled breath condensate collection. Allergy Eur J Allergy Clin Immunol. 2006;61(8):1016–1018.
   Web of Science ®Google Scholar
• Kononikhin AS, Starodubtseva NL, Chagovets, et al. Exhaled breath condensate analysis from intubated newborns by nano-HPLC coupled to high resolution MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1047:97–105.
   PubMed Web of Science ®Google Scholar
• Zamuruyev KO, Schmidt AJ, Borras E, et al. Power-efficient self-cleaning hydrophilic condenser surface for portable exhaled breath condensate (EBC) metabolomic sampling. J Breath Res. 2018;12(3):036020.
   PubMed Web of Science ®Google Scholar
• National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409.
   PubMed Web of Science ®Google Scholar
• Pinsky PF, Berg CD. Applying the national lung screening trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered? J Med Screen. 2012;19(3):154–156.
   PubMed Web of Science ®Google Scholar
• Brothers JF, Hijazi K, Mascaux C, et al. Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-national lung screening trial era. BMC Med. 2013;11(1):168.
   PubMed Web of Science ®Google Scholar
• Hasan N, Kumar R, Kavuru MS. Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers. Lung. 2014;192(5):639–648.
   PubMed Web of Science ®Google Scholar
• Spira A, Beane JE, Shah V, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med. 2007;13(3):361–366.
   PubMed Web of Science ®Google Scholar
• Beane J, Sebastiani P, Whitfield TH, et al. A prediction model for lung cancer diagnosis that integrates genomic and clinical features. Cancer Prev Res (Phila). 2008;1(1):56–64.
   PubMed Web of Science ®Google Scholar
• Schmidt B, Liebenberg V, Dietrich D, et al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer. 2010;10(1):600.
   PubMed Web of Science ®Google Scholar
• Rahman SM, Gonzalez AL, Li M, et al. Lung cancer diagnosis from proteomic analysis of preinvasive lesions. Cancer Res. 2011;71(8):3009–3017.
   PubMed Web of Science ®Google Scholar
• Xing L, Todd NW, Yu L, et al. Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol. 2010;23(8):1157–1164.
   PubMed Web of Science ®Google Scholar
• Yu L, Todd NW, Xing L, et al. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer. 2010;127(12):2870–2878.
   PubMed Web of Science ®Google Scholar
• Kononikhin AS, Brzhozovskiy AG, Ryabokon AM, et al. Proteome profiling of the exhaled breath condensate after long-term spaceflights. Int J Mol Sci. 2019;20(18):4518.
   Web of Science ®Google Scholar
• Phillips M, Cataneo RN, Cummin AR, et al. Detection of lung cancer with volatile markers in the breath. Chest. 2003;123(6):2115–2123.
   PubMed Web of Science ®Google Scholar
• Phillips M, Altorki N, Austin JH, et al. Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark. 2007;3(2):95–109.
   PubMedGoogle Scholar
• Machado RF, Laskowski D, Deffenderfer O, et al. Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med. 2005;171(11):1286–1291.
   PubMed Web of Science ®Google Scholar
• Mazzone PJ, Hammel J, Dweik R, et al. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax. 2007;62(7):565–568.
   PubMed Web of Science ®Google Scholar
• McCulloch M, Jezierski T, Broffman M, et al. Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther. 2006;5(1):30–39.
   PubMed Web of Science ®Google Scholar